chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Elevated or racing heart/ My heart rate has been jumping over 130 with Simple activities like brushing my teeth/ elevated HR 130-150s; This is a spontaneous report from a contactable other health care professional (patient). A 33-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown) via an unspecified route of administration in Arm Right on 20Mar2021 09:15 (at the age of 33 years old, unknown if patient pregnant) as dose 1, single for Covid-19 immunization. Medical history reported as none. Patient did not have allergies to medications, food, or other products. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient has not been tested for Covid-19. The patient experienced elevated or racing heart/ my heart rate has been jumping over 130 with simple activities like brushing my teeth/ elevated heart rate 130-150s on 21Mar2021. Event reported as, elevated or racing heart. patient was very physically fit person with an average resting heart rate in the 50's. Patient heart rate has been jumping over 130 with simple activities like brushing her teeth. Patient was well hydrated and no fever. Elevated heart rate 130-150s. 100 resting. She was asking for a recommendation on receipt of second dose. She received her first dose 20Mar2021, and on Sunday, patient heart rate was super elevated. Her resting would not go under 100 and with any little activity, would jump up to 150. The day after was fine and she has been fine since. She is scheduled to get next dose 10Apr2021, and wants to make sure it is safe for her to get it. No treatment received for the adverse event. The patient underwent lab tests and procedures which included heart rate: resting would not go under 100 and with any little activity, would jump up to 150 on an unspecified date. Outcome of the event was resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Within a few minutes after my 1st Covid 19 vaccine my throat and tongue began to swell up; Within a few minutes after my 1st Covid 19 vaccine my throat and tongue began to swell up; Skin started to turn red all over; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 14:00, within few minutes after the first vaccine patient's throat and tongue began to swell up and the skin started to turn red all over. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with diphenhydramine (BENADRYL) on site by a Registered Nurse. The clinical outcome of the events throat swelling, tongue swelling and skin started to turn red all over was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pharyngeal swelling, Swollen tongue
Clinical narrative: Within a few minutes after my 1st Covid 19 vaccine my throat and tongue began to swell up; Within a few minutes after my 1st Covid 19 vaccine my throat and tongue began to swell up; Skin started to turn red all over; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 14:00, within few minutes after the first vaccine patient's throat and tongue began to swell up and the skin started to turn red all over. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with diphenhydramine (BENADRYL) on site by a Registered Nurse. The clinical outcome of the events throat swelling, tongue swelling and skin started to turn red all over was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deafness, Tinnitus
Clinical narrative: Severe tinnitus in left ear; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 15:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 07:00, the patient experienced severe tinnitus in left ear appeared 11 days after injection. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe tinnitus in left ear and included treatment with unspecified steroids. The clinical outcome of the event severe tinnitus in left ear was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Severe tinnitus in left ear; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 15:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 07:00, the patient experienced severe tinnitus in left ear appeared 11 days after injection. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe tinnitus in left ear and included treatment with unspecified steroids. The clinical outcome of the event severe tinnitus in left ear was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Cough, Dizziness, Fatigue, Headache
Clinical narrative: blood blisters on every part of body; fever; scratchy throat; chills; headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 25Mar2021 at 00:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included pulmonary fibrosis from sarcoids of lungs and lympth nodes. The patient was allergic to latex. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, second day, the patient experienced fever, scratchy throat, chills, headache. On 28Mar2021, third day, the patient experienced all above plus blood blisters on every part of her body. (Arm did not hurt). No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, scratchy throat, chills, headache and the event blood blisters on every part of body were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oropharyngeal pain, Pain in jaw, Palpitations, Pyrexia
Clinical narrative: blood blisters on every part of body; fever; scratchy throat; chills; headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 25Mar2021 at 00:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included pulmonary fibrosis from sarcoids of lungs and lympth nodes. The patient was allergic to latex. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, second day, the patient experienced fever, scratchy throat, chills, headache. On 28Mar2021, third day, the patient experienced all above plus blood blisters on every part of her body. (Arm did not hurt). No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, scratchy throat, chills, headache and the event blood blisters on every part of body were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood blister, Chills, Headache, Oropharyngeal discomfort, Pyrexia
Clinical narrative: blood blisters on every part of body; fever; scratchy throat; chills; headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 25Mar2021 at 00:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included pulmonary fibrosis from sarcoids of lungs and lympth nodes. The patient was allergic to latex. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, second day, the patient experienced fever, scratchy throat, chills, headache. On 28Mar2021, third day, the patient experienced all above plus blood blisters on every part of her body. (Arm did not hurt). No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, scratchy throat, chills, headache and the event blood blisters on every part of body were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood blister, Chills, Cough, Headache, Pyrexia
Clinical narrative: blood blisters on every part of body; fever; scratchy throat; chills; headache; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 25Mar2021 at 00:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included pulmonary fibrosis from sarcoids of lungs and lympth nodes. The patient was allergic to latex. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, second day, the patient experienced fever, scratchy throat, chills, headache. On 28Mar2021, third day, the patient experienced all above plus blood blisters on every part of her body. (Arm did not hurt). No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, scratchy throat, chills, headache and the event blood blisters on every part of body were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Rash macular, Skin irritation
Clinical narrative: Itchy spots on arms; Hives all over my body/Hives for 5 months; Loss of hair; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received dose 2 of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine), via an unspecified route of administration, administered in the left arm on 26Feb2021 at 10:45 (also reported as 11:00 AM) (Batch/Lot Number: EN6198) single, for COVID-19 immunization. Medical history included Sjogren's syndrome and had known allergies to penicillin, Bactrim, Cypro, sulfur, clindamycin, and tetracycline. The patient was not pregnant at the time of vaccination and was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included omeprazole, trazodone, Vitamin E, Vitamin D3, Multivitamins, Vitamin B6, and Calcium, taken for unspecified indications, start and stop dates were not reported. The patient received other vaccines within 4 weeks prior to the COVID vaccine (unspecified; also reported as had not received). The patient previously received dose 1 of BNT162B2 on 03Feb2021 at 03:30 PM (Lot number: EM9810) in the left arm for COVID-19 immunization. On 01Mar2021 at 10:00 AM, the patient experienced hives for 5 months and loss of hair. On 04Mar2021, one week after the shot, the patient began to get itchy spots on the arms. It was also reported that shortly thereafter, she began with hives all over her body. As of 22Apr2021, the patient was reported to be still suffering. She was taking double doses of antihistamines, Atarax, and prednisone, and had seen a dermatologist. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the event alopecia was recovered with sequelae (reported as recovered with lasting effects) on an unspecified date, while for the other events was not recovered. The case was reported as non-serious.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Pruritus, Urticaria
Clinical narrative: Itchy spots on arms; Hives all over my body/Hives for 5 months; Loss of hair; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received dose 2 of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine), via an unspecified route of administration, administered in the left arm on 26Feb2021 at 10:45 (also reported as 11:00 AM) (Batch/Lot Number: EN6198) single, for COVID-19 immunization. Medical history included Sjogren's syndrome and had known allergies to penicillin, Bactrim, Cypro, sulfur, clindamycin, and tetracycline. The patient was not pregnant at the time of vaccination and was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included omeprazole, trazodone, Vitamin E, Vitamin D3, Multivitamins, Vitamin B6, and Calcium, taken for unspecified indications, start and stop dates were not reported. The patient received other vaccines within 4 weeks prior to the COVID vaccine (unspecified; also reported as had not received). The patient previously received dose 1 of BNT162B2 on 03Feb2021 at 03:30 PM (Lot number: EM9810) in the left arm for COVID-19 immunization. On 01Mar2021 at 10:00 AM, the patient experienced hives for 5 months and loss of hair. On 04Mar2021, one week after the shot, the patient began to get itchy spots on the arms. It was also reported that shortly thereafter, she began with hives all over her body. As of 22Apr2021, the patient was reported to be still suffering. She was taking double doses of antihistamines, Atarax, and prednisone, and had seen a dermatologist. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the event alopecia was recovered with sequelae (reported as recovered with lasting effects) on an unspecified date, while for the other events was not recovered. The case was reported as non-serious.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: hives; rash all over the body; she almost passed out; bloated stomach; stomach pain; This is a spontaneous report from a contactable consumer (patient) received via a Pfizer-sponsored program. A 54-year-old female consumer (patient) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 27Mar2021 (Batch/Lot number: ED6955; also reported as EP6955) (at the age of 54-years-old) as dose 1, single for COVID-19 immunisation. The patient has no medical history and no concomitant medications. The patient received first dose of the vaccine on 27Mar2021, then two days later (on 29Mar2021), she developed a bloated stomach, and stomach pain. She had so much stomach pain she almost passed out. Two days after that (four days after the vaccine on 31Mar2021) she developed hives and that's when she went to urgent care.  She sought out medical assistance and had prednisone shots for 5 days and took Benadryl for 2 weeks for her symptoms. She was asking if it is safe for her to take the second dose of the COVID vaccine. Patient said that she has gotten different opinions from different doctors so that didn't help her. Her reaction was a pretty bad reaction. Two days after her stomach was bloated, she got hives and when she went to urgent care her stomach was still hard like a rock, it was crazy. It was so bad she had to call her husband and get him to come home from work because she felt like she was passing out. After that she got hives which lasted for 2 weeks but because she was on Benadryl, she didn't get a lot of hives after that and she had already taken prednisone. Patient clarified that she had problems with her stomach for probably about 2 weeks and then the hives lasted about two weeks too. After the prednisone, she had to take Benadryl. Both things lasted for quite some time. The doctor who treated her told her to not go for the 2nd dose because she could have anaphylaxis since the second is usually stronger than first. But her primary doctor, who wouldn't even get on the phone, just said to take two Tylenol and go get the second. She didn't think that was very smart because if she is not being treated with anything, she can't just take Tylenol if she had just had a bad reaction. Upon follow-up on 02Aug2021, the patient reported that she had a rash all over the body and had stomach problems. The outcome of the events was recovered in Apr2021.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100985870 similar report from same reporter
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Abdominal pain upper, Presyncope, Rash, Urticaria
Clinical narrative: hives; rash all over the body; she almost passed out; bloated stomach; stomach pain; This is a spontaneous report from a contactable consumer (patient) received via a Pfizer-sponsored program. A 54-year-old female consumer (patient) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 27Mar2021 (Batch/Lot number: ED6955; also reported as EP6955) (at the age of 54-years-old) as dose 1, single for COVID-19 immunisation. The patient has no medical history and no concomitant medications. The patient received first dose of the vaccine on 27Mar2021, then two days later (on 29Mar2021), she developed a bloated stomach, and stomach pain. She had so much stomach pain she almost passed out. Two days after that (four days after the vaccine on 31Mar2021) she developed hives and that's when she went to urgent care.  She sought out medical assistance and had prednisone shots for 5 days and took Benadryl for 2 weeks for her symptoms. She was asking if it is safe for her to take the second dose of the COVID vaccine. Patient said that she has gotten different opinions from different doctors so that didn't help her. Her reaction was a pretty bad reaction. Two days after her stomach was bloated, she got hives and when she went to urgent care her stomach was still hard like a rock, it was crazy. It was so bad she had to call her husband and get him to come home from work because she felt like she was passing out. After that she got hives which lasted for 2 weeks but because she was on Benadryl, she didn't get a lot of hives after that and she had already taken prednisone. Patient clarified that she had problems with her stomach for probably about 2 weeks and then the hives lasted about two weeks too. After the prednisone, she had to take Benadryl. Both things lasted for quite some time. The doctor who treated her told her to not go for the 2nd dose because she could have anaphylaxis since the second is usually stronger than first. But her primary doctor, who wouldn't even get on the phone, just said to take two Tylenol and go get the second. She didn't think that was very smart because if she is not being treated with anything, she can't just take Tylenol if she had just had a bad reaction. Upon follow-up on 02Aug2021, the patient reported that she had a rash all over the body and had stomach problems. The outcome of the events was recovered in Apr2021.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100985870 similar report from same reporter
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Large rash in underarm; Abdominal Cramping; Diarrhea - 6 hours; This is a spontaneous report from a contactable consumer (patient). A 48-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL9267, expiration date was not reported), via an unspecified route of administration, administered in right arm on 12Feb2021 14:00 (at the age of 48-years-old) as dose 1, single for covid-19 immunization at workplace clinic. The patient medical history included Immunocompromised, MS (multiple sclerosis). Concomitant medications were not reported.  The patient previously took copaxone and experienced drug hypersensitivity (known allergies: Copaxone).  Patient did not receive any other vaccine in four weeks. Patient did not receive any other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that, on 15Feb2021 the patient experienced large rash in underarm - doctor prescribed a steroid ointment abdominal cramping and diarrhea - 6 hours. Therapeutic measures were taken as a result of large rash in underarm, abdominal cramping, diarrhea - 6 hours. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Topical steroid was received as treatment. The outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Diarrhoea, Rash
Clinical narrative: Large rash in underarm; Abdominal Cramping; Diarrhea - 6 hours; This is a spontaneous report from a contactable consumer (patient). A 48-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL9267, expiration date was not reported), via an unspecified route of administration, administered in right arm on 12Feb2021 14:00 (at the age of 48-years-old) as dose 1, single for covid-19 immunization at workplace clinic. The patient medical history included Immunocompromised, MS (multiple sclerosis). Concomitant medications were not reported.  The patient previously took copaxone and experienced drug hypersensitivity (known allergies: Copaxone).  Patient did not receive any other vaccine in four weeks. Patient did not receive any other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that, on 15Feb2021 the patient experienced large rash in underarm - doctor prescribed a steroid ointment abdominal cramping and diarrhea - 6 hours. Therapeutic measures were taken as a result of large rash in underarm, abdominal cramping, diarrhea - 6 hours. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Topical steroid was received as treatment. The outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Jaw disorder
Clinical narrative: numbing and tingling on face, hands lips and tongue; numbing and tingling on face, hands lips and tongue; This is a spontaneous report from a contactable consumer (patient). A 61-years-old female non-pregnant patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), via an unspecified route of administration, administered in Arm Left on 09Mar2021 11:00 (at the age of 61-years-old) (Batch/Lot number was not reported) as dose number unknown. single for COVID-19 immunisation. Medical history included asthma and allergy to metals and dyes from an unknown date and unknown if ongoing known allergies. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), atomoxetine hydrochloride (STRATTERA), salbutamol (VENTOLINE) and budesonide, formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported. The patient had not received other vaccine in four weeks, the patient had no prior vaccination and covid test post vaccination. The patient experienced numbing and tingling on face, hands lips and tongue on 09Mar2021 11:00. The patient received treatment of antihistamine in response to event. The clinical outcome of events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: numbing and tingling on face, hands lips and tongue; numbing and tingling on face, hands lips and tongue; This is a spontaneous report from a contactable consumer (patient). A 61-years-old female non-pregnant patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), via an unspecified route of administration, administered in Arm Left on 09Mar2021 11:00 (at the age of 61-years-old) (Batch/Lot number was not reported) as dose number unknown. single for COVID-19 immunisation. Medical history included asthma and allergy to metals and dyes from an unknown date and unknown if ongoing known allergies. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), atomoxetine hydrochloride (STRATTERA), salbutamol (VENTOLINE) and budesonide, formoterol fumarate (SYMBICORT) taken for an unspecified indication, start and stop date were not reported. The patient had not received other vaccine in four weeks, the patient had no prior vaccination and covid test post vaccination. The patient experienced numbing and tingling on face, hands lips and tongue on 09Mar2021 11:00. The patient received treatment of antihistamine in response to event. The clinical outcome of events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: "Electric shock" feeling spread to left hand and both feet.; "Began with numbness in right hand/ Over three weeks, numbness spread to left hand and both feet/ numbness then spread up calves"; Increased to "carpal tunnel" type symptoms; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included connective tissue/autoimmune disorder with rheumatoid arthritis. The patient reported that she had been treated by a rheumatologist for many years. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL), cyclobenzaprine (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN) and atorvastatin calcium (LIPITOR); all for unknow indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 at 12:00, the patient reported that the numbness began in right hand, which increased to "carpal tunnel" type symptoms. Over three weeks, on an unspecified date in Apr2021, the numbness and "electric shock" feeling spread to the left hand and both feet. The numbness then spread up the calves. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with a steroid pack to reduce the inflammation. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent a nasal swab test and tested negative. The clinical outcome of the events numbness began in right hand, which increased to "carpal tunnel" type symptoms, numbness and "electric shock" feeling spread to the left hand and both feet and the numbness then spread up the calves was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Carpal tunnel syndrome, Electric shock, Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: "Electric shock" feeling spread to left hand and both feet.; "Began with numbness in right hand/ Over three weeks, numbness spread to left hand and both feet/ numbness then spread up calves"; Increased to "carpal tunnel" type symptoms; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included connective tissue/autoimmune disorder with rheumatoid arthritis. The patient reported that she had been treated by a rheumatologist for many years. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL), cyclobenzaprine (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN) and atorvastatin calcium (LIPITOR); all for unknow indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 at 12:00, the patient reported that the numbness began in right hand, which increased to "carpal tunnel" type symptoms. Over three weeks, on an unspecified date in Apr2021, the numbness and "electric shock" feeling spread to the left hand and both feet. The numbness then spread up the calves. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with a steroid pack to reduce the inflammation. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent a nasal swab test and tested negative. The clinical outcome of the events numbness began in right hand, which increased to "carpal tunnel" type symptoms, numbness and "electric shock" feeling spread to the left hand and both feet and the numbness then spread up the calves was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: "Electric shock" feeling spread to left hand and both feet.; "Began with numbness in right hand/ Over three weeks, numbness spread to left hand and both feet/ numbness then spread up calves"; Increased to "carpal tunnel" type symptoms; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included connective tissue/autoimmune disorder with rheumatoid arthritis. The patient reported that she had been treated by a rheumatologist for many years. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL), cyclobenzaprine (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN) and atorvastatin calcium (LIPITOR); all for unknow indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 at 12:00, the patient reported that the numbness began in right hand, which increased to "carpal tunnel" type symptoms. Over three weeks, on an unspecified date in Apr2021, the numbness and "electric shock" feeling spread to the left hand and both feet. The numbness then spread up the calves. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with a steroid pack to reduce the inflammation. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent a nasal swab test and tested negative. The clinical outcome of the events numbness began in right hand, which increased to "carpal tunnel" type symptoms, numbness and "electric shock" feeling spread to the left hand and both feet and the numbness then spread up the calves was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Pruritus, Swollen tongue
Clinical narrative: swollen tongue and face; swollen tongue and face; This is a spontaneous report from a contactable consumer (patient herself). A 87-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 29Jan2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Caller received the Pfizer-BioNTech COVID-19 Vaccine first dose Friday, 29Jan2021. She is scheduled for the second dose on 19Feb2021. Caller mentioned that when she got up the next day (30Jan2021), she had a swollen tongue and face. This prompted her to go to her primary doctor, and doctor advised her not to get other dose of the vaccine. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Swollen tongue
Clinical narrative: swollen tongue and face; swollen tongue and face; This is a spontaneous report from a contactable consumer (patient herself). A 87-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 29Jan2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Caller received the Pfizer-BioNTech COVID-19 Vaccine first dose Friday, 29Jan2021. She is scheduled for the second dose on 19Feb2021. Caller mentioned that when she got up the next day (30Jan2021), she had a swollen tongue and face. This prompted her to go to her primary doctor, and doctor advised her not to get other dose of the vaccine. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aphonia, Balance disorder, Chills, Disturbance in attention, Dizziness
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Eye pruritus, Fatigue, Feeling abnormal, Gait disturbance
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Goitre, Headache, Heart rate, Heart rate increased, Lip erythema
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lip oedema, Oxygen saturation, Paraesthesia oral, Somnolence, Speech disorder
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tinnitus, Vaccination site pruritus, Vaccination site warmth, Vertigo
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Aphasia, Chills, Confusional state, Dizziness
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Eye pruritus, Fatigue, Feeling abnormal, Feeling cold
Clinical narrative: an elevated heart rate; problems with breathing; This is a spontaneous report from a contactable consumer (patient), received from a Pfizer sponsored program COVAX US Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 15Mar2021, as dose 1, single for COVID-19 immunization. The patient's medical history included lot of allergies. Concomitant medications were not reported. The patient's past drugs included Benadryl and Epipen, and experienced allergy with both drugs. On 15Mar2021, within a few minutes after the first dose of vaccine, the patient experienced an elevated heart rate and problems with breathing. Patient received a note from her doctor stating that she cannot get the second dose as well. Patient underwent lab test and procedures which included heart rate: an elevated heart rate, on an unspecified date. The clinical outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.